HUMAN MONOCLONAL ANTIBODIES TO TNF: NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC SPONDYLITIS
<em>This article contains an example of a successful clinical use of human monoclonal antibodies to tumor necrosis factor (TNF) - adalimumab in patients with severe juvenile idiopathic spondylitis, characterized by resistance to standard antirheumatic treatment and secondary resistance to reco...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | |
| Опубликовано: |
"Paediatrician" Publishers LLC,
2011-01-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |